NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer
PHASE2
This phase II trial evaluates whether early switching from modified fluorou...
Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations
PHASE1
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3
PHASE4
In countries with a high tuberculosis (TB) prevalence, TB and invasive bact...
Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers
N/A
This is a protocol to collect tissues, blood, and other specimens from pati...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2004-02
Trial ID
NCT00580203
Use of Cidofovir for Recurrent Respiratory Papillomatosis
PHASE4
Recurrent respiratory papillomatosis (RRP) is the most common benign neopla...